Home / CHF / Novostia raises CHF 6.5 million to advance its aortic, mitral heart valve to clinical trials

Novostia raises CHF 6.5 million to advance its aortic, mitral heart valve to clinical trials

Novostia announces that it raised CHF 6.5 million from private investors to advance its disruptive aortic and mitral heart valve to clinical trials. Heart valve diseases affect more than 100 million p…
Read Full Story at source (may require registration)